Wegener granulomatosis: Case report and brief literature review

Journal of the American Board of Family Practice

Volumn 16, Issue 6, 2003, Pages 555-559

  Shafiei, Khaled ^a,c   Luther, Euil ^a   Archie, Michael ^a   Gulick, Janis ^a   Fowler, Marjorie R ^b  

^a Lousiana State University Health Sciences Center   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c E A Conway Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IBUPROFEN; INDOMETACIN; LEVOFLOXACIN; LORATADINE; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DYSURIA; HEMATURIA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LUNG TUMOR; MALE; PHYSICAL EXAMINATION; SINUSITIS; TUMOR BIOPSY; WEGENER GRANULOMATOSIS; BLOOD; BLOOD EXAMINATION; DIFFERENTIAL DIAGNOSIS; LUNG; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, FINE-NEEDLE; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG NEOPLASMS; MALE; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 3543061132     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.16.6.555     Document Type: Article

References (30)

1. Lie JT. Illustrated histologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
2. Hewins P, Tervaert JW, Savage CO, Kallenberg CG. Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol 2000;12:3-10.
3. Watts RA. Wegener's granulomatosis: unusual presentations. Hosp Med 2000;61:250-3.
4. Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 1995;21:987-1011.
5. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
6. Schmacher HR, Klippel JH, Koopman WJ, editors. Primer on the rheumatic disease. Atlanta: Arthritis Foundation; 1993. p. 136-48.
7. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
8. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973;52:535-61.
9. Anderson G, Coles ET, Crane M, et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Scociety Research Committee. Q J Med 1992;83:427-38.
10. Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983;90:279-90.
11. Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of literature. Am J Med 1977;63:131-41.
12. Klinger H. Grenzforman der periarteritis nodosa. Frankfurt Z Pathol 1931;42:455-80.
13. De Oreo GA. Wegener's granulomatosis. Arch Dermatol 1960;81:169-74.
14. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's Granulomatosis). Br Med J 1958;2:265-70.
15. Aymard B, Bigard MA, Thompson H, Schmutz JL, Finet JF, Borrelly J. Perianal ulcer: an unusual presentation of Wegener's granulomatosis. Report of a case. Dis Colon Rectum 1990;33:427-30.
16. Wilson RT, Dean PJ, Upshaw JD, Wruble LD. Endoscopic appearance of Wegener's granulomatosis involving the colon. Gastrointest Endosc 1987;33:388-9.
17. Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener's granulomatosis and the heart. Br Heart J 1994;71:82-6.
18. Schiavone WA, Ahmad M, Ockner SA. Unusual cardiac complications of Wegener's granulomatosis. Chest 1985;88:745-8.
19. Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990;89:403-10.
20. Gross WL, Rasmussen N. Treatment of Wegener's granulomatosis: the view from two non-nephrologists. Nephrol Dial Transplant 1994;9:1219-22.
21. Guillevin L, Cordier J-F, Lhote F, et al. A prospective multicenter randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40:2187-98.
22. Haubitz M, Schellong S, Gobel U, et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective randomized study. Arthritis Rheum 1998;41:1835-44.
23. Adu D, Pall A, Luqmani RA, et al. Controlled trial of pulse versus continuous prednisone and cyclophosphamide in the treatment of systemic vasculitis. QJM 1997;90:401-9.
24. de Groot K, Adu D, Savage CO. The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001;16:2018-27.
25. Langford CA, Sneller MC, Hoffman GS. Methotrexate use in systemic vasculitis. Rheum Dis Clin North Am 1997;23:841-53.
26. Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerolonephritis. Arthritis Rheum 2000;43:1836-40.
27. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-63.
28. Cole E, Cattran D, Magil A, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 1992;20:261-9.
29. Zauner I, Bach D, Braun N, et al. Predictive value of initial histology and effects of plasmaphoresis on long-term prognosis of rapidly progressive glomerulonephritis. Am J Kidney Dis 2002;39:28-35.
30. Guillevin L, Lhote F, Cohen P, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995;38:1638-45.